Trade KYNB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kyntra Bio, Inc. (KYNB) is trading at US$6.31, down 2.92% today as of Oct 2, 16:00 EDT. The company has a market capitalisation of US$30.45M. Over the past 52 weeks, KYNB has traded between US$6.30 and US$12.13. On Syfe you can trade KYNB with $0 commission and add it to your watchlist.
| Previous close | US$6.50 |
|---|---|
| Market cap | US$30.45M |
| 52-week range | US$6.30 – US$12.13 |
| Volume | 26.08K |
| Exchange | US |
Kyntra Bio, Inc.
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Year: 2014
Kyntra Bio Cuts Royalty Payments to NQ Project Phoebus for Accelerated Upfront Payment
Aug 31, 9:37 PM · MT Newswires
--Oppenheimer Initiates Kyntra Bio at Outperform With $35 Price Target
Jul 7, 12:36 PM · MT Newswires
Kyntra Bio Receives Final $4 Million Payment Under 2025 Share Purchase Deal With AstraZeneca
Jun 10, 11:00 AM · MT Newswires
Kyntra Bio, Inc. (KYNB) stock is trading at US$6.31, -2.92% from the previous close of US$6.50.
The market cap for Kyntra Bio, Inc. (KYNB) stock is approximately US$30.45M.
The 52-week high for Kyntra Bio, Inc. (KYNB) stock is US$12.13.
The 52-week low for Kyntra Bio, Inc. (KYNB) stock is US$6.30.
Kyntra Bio, Inc. (KYNB) does not currently pay a dividend.
Stay on top of KYNB
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
